Search results
Pakistan probes distributors of Roche cancer drug after patients go blind
Reuters via Yahoo News· 9 months agoLAHORE, Pakistan (Reuters) -Pakistan said on Monday it was investigating two local distributors of...
What This News Means for Merck
Motley Fool· 2 years agoIn combination with Roche's (OTC: RHHBY) bevacizumab (Avastin), Merck's (NYSE: MRK) oncology medicine -- co-owned with AstraZeneca (NASDAQ: AZN) and...
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Biotech Giant Regeneron Hit As Eylea Gives Ground To Avastin
Investor's Business Daily· 1 year agoBiotech giant Regeneron Pharmaceuticals said Monday that sales of its linchpin Eylea drug in the...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
MacTel2 Treatment: With Easier Ways to Adapt to Vision Loss
Verywell Health via Yahoo News· 17 hours agoMedication, Surgery, and Lifestyle Adjustments Medically reviewed by Johnstone M. Kim, MDMedically...
Ovarian cancer patient hails treatment as a 'lifeline'
BBC via Yahoo News· 16 hours agoA terminally ill woman who has lived longer than doctors predicted has said she has been given a lifeline thanks to a new treatment. Christine Campbell, from Dundonald was diagnosed with stage-four ...
Regeneron (REGN) Down on Ophthalmology Drug Eylea Sales Update
Zacks via Yahoo Finance· 1 year agoShares of Regeneron Pharmaceuticals, Inc. REGN were down 7.69% after the company announced that its...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...